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Filling the Gaps in the Kirromycin 
Biosynthesis: Deciphering the Role 
of Genes Involved in Ethylmalonyl-
CoA Supply and Tailoring Reactions
Helene L. Robertsen1, Ewa M. Musiol-Kroll1,2,3, Ling Ding1, Kristina J. Laiple2, Torben 
Hofeditz4, Wolfgang Wohlleben2,3, Sang Yup Lee  1,5, Stephanie Grond4 & Tilmann Weber  1
Kirromycin is the main product of the soil-dwelling Streptomyces collinus Tü 365. The elucidation of the 
biosynthetic pathway revealed that the antibiotic is synthesised via a unique combination of trans-
/cis-AT type I polyketide synthases and non-ribosomal peptide synthetases (PKS I/NRPS). This was 
the first example of an assembly line integrating the three biosynthetic principles in one pathway. 
However, information about other enzymes involved in kirromycin biosynthesis remained scarce. In 
this study, genes encoding tailoring enzymes KirM, KirHVI, KirOI, and KirOII, and the putative crotonyl-
CoA reductase/carboxylase KirN were deleted, complemented, and the emerged products analysed by 
HPLC-HRMS and MS/MS. Derivatives were identified in mutants ΔkirM, ΔkirHVI, ΔkirOI, and ΔkirOII. 
The products of ΔkirOI, ΔkirOII, and kirHVI were subjected to 2D-NMR for structure elucidation. 
Our results enabled functional assignment of those enzymes, demonstrating their involvement in 
kirromycin tailoring. In the ΔkirN mutant, the production of kirromycin was significantly decreased. 
The obtained data enabled us to clarify the putative roles of the studied enzymes, ultimately allowing 
us to fill many of the missing gaps in the biosynthesis of the complex antibiotic. Furthermore, this 
collection of mutants can serve as a toolbox for generation of new kirromycins.
Streptomycetes are known for their profound ability to produce a diverse set of secondary metabolites with rele-
vant pharmaceutical properties, including, but not limited to, antibiotics, anti-fungals, immunosuppressant, and 
antitumor agents. Polyketides comprise a noteworthy subset of these metabolites. They played and still play an 
important role in the clinic1,2, hence highlighting the importance of their discovery.
Polyketides are synthesised by megaenzyme complexes termed modular polyketide synthases (PKSs), which 
catalyse the controlled initiation and elongation of simple carboxylic acid monomers into polyketide chains. One 
example of a complex polyketide is the narrow-spectrum antibiotic kirromycin. The compound was first isolated 
from the soil-dwelling Streptomyces collinus Tü 365 in 19723. The linear molecule is composed of three internal 
ring structures: a pyridone ring, a central tetrahydrofuran (THF) group, and a sugar-like moiety, also referred 
as goldinonic acid4 (Fig. 1A). These three kirromycin moieties are directly involved in the binding of the antibi-
otic kirromycin to the elongation factor (EF) Tu in prokaryotes5,6. This interaction prevents the conformational 
change between the GTP- and GDP-bound form of the EF Tu, which results in stalling of protein biosynthesis.
Although the structure and activity of kirromycin were known since the early 70s, most of the biosynthetic 
steps remained unexplored. After the 82 kb kirromycin cluster (Fig. 1B), encoding 28 genes, was identified 
and described4, more details on the assembly of the compound were obtained. The hypothetical pathway of 
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kirromycin indicated that the biosynthetic steps involve non-ribosomal peptide synthetases (NRPSs), acyltrans-
ferase (AT)-harbouring PKSs (cis-AT PKSs), AT-less PKSs (trans-AT PKSs), and several tailoring enzymes. This 
first description of a biosynthetic pathway involving three different types of multi-modular enzymes has made the 
assembly line a relevant model for studying complex cis-/trans-AT PKS/NRPS pathways.
Directly upstream of the PKS/NRPS genes in the BGC of kirromycin, the Sfp-type phosphopantetheinyl trans-
ferase (PPTase) KirP, responsible for the post-translational activation of PKS acyl carrier proteins (ACPs) and 
NRPS peptidyl carrier proteins (PCPs), was identified7. The core PKS/NRPS enzymes in kirromycin are encoded 
by kirAI – kirAVI and kirB4. Closer examinations of the PKS-related genes and their products revealed KirAVI to 
be the only cis-AT PKS in the assembly line. The upstream PKSs, KirAI – KirAV, lack the integrated ATs. For these 
modules, extender units are provided by the discrete ATs KirCI8,9 and KirCII8,10, which provide malonyl-CoA and 
ethylmalonyl-CoA to the ACPs of the assembly line. The last core enzyme of the kirromycin PKS/NRPS assembly 
line is encoded by kirB. The protein KirB is responsible for incorporation of the precursor β-alanine4, which is 
biosynthesised by the aspartate-α-decarboxylase encoded by kirD11. Upon release from the assembly line, this 
precursor is cyclised to form the pyridone ring4. Interestingly, no genes encoding a typical thioesterase (TE) were 
found in the kirromycin biosynthetic gene cluster (BGC). Recently, Gui et al.12 reported the discovery of a new 
group of Dieckmann cyclases involved in the biosynthesis of tetramic acid and pyridone scaffolds. A member of 
this new family of enzymes was also identified in the kirromycin BGC. KirHI, previously assigned with a hypo-
thetical function, was found to catalyse pyridone ring closure and the co-occurring release of the molecule chain 
from the PKS I/NRPS assembly line12.
While the precursor loading of the PKS I/NRPS modules and the kirromycin polyketide chain elongation 
are well investigated, only limited knowledge about the provision of ethylmalonyl-CoA and the final tailoring 
reactions is available for this pathway. To date, the underlying reactions leading to the THF ring closure, the 
introduction of hydroxyl groups at C-16 and C-30, methylation of the oxygen at O-42, and the formation of the 
double bond between C-5 and C-6 in the pyridone ring have remained elusive. These enzymatic reactions cannot 
be explained from the enzymatic domains encoded within the PKS I/NRPS complex, and thus it was speculated 
that those product modifications are achieved through tailoring reactions.
In this study, the genes kirM, kirHVI, kirOI, kirOII, kirHIV, kirHV, and kirN, which are encoded in the kirro-
mycin BGC but have no experimentally determined function, were examined by genetic inactivation and gene 
complementation. The compounds produced by the gene inactivation mutants were analysed and characterised 
by high performance liquid chromatography (HPLC)–high-resolution mass spectrometry (HRMS), and MS/
MS. In addition, nuclear magnetic resonance (NMR) was employed for structural elucidation of the derivative 
produced by the ΔkirHVI, ΔkirOI, and ΔkirOII mutants.
Figure 1. The structure and biosynthetic gene cluster of kirromycin. (A) Kirromycin is composed of three 
intramolecular ring structures; a pyridone ring, a central tetrahydrofuran (THF) ring, and a sugar-like 
moiety termed goldinonic acid4. (B) Modified graphics from Weber et al.4. Black, Hypothetical proteins; Blue, 
NRPS-related genes; Red, PKS-related genes; Orange, Dehydrogenases and hydroxylases; Light blue, Genes 
involved in precursor supply; Light brown, O-methyltransferase; Light green, Transport-related genes; Purple, 
Regulatory genes; Light grey, Genes putatively not involved in kirromycin biosynthesis. Genes studied here are 
in bold and have been underlined.
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Methods
Bacterial strains and general growth conditions. Plasmids and strains used in this study are listed 
in Supplementary Table S1. Wild type strain Streptomyces collinus Tü 365 was obtained from the “Tübinger 
Stammsammlung”. For routine cultivations of mutants, complemented mutants, and wild type strain, Tryptic Soy 
Broth (TSB) supplemented with nalidixic acid (25 μg/mL) was used. Furthermore, complemented mutants were 
propagated in the presence of apramycin (50 μg/mL). Sporulation of wild type and mutant strains was performed 
on modified SFM agar (2% mannitol, 2% full fat soy flour, 20 mM MgCl2, 20 mM CaCl2, tap water). Escherichia 
coli DH5-α was used for standard cloning procedure of pGUSA21, pDrive, pA18mob, pJet1.2/blunt, pGM1190, 
and pRM4 constructs. Transformation was carried out according to the manufacturer’s specifications and includ-
ing a 1 h recovery step in Super Optimal broth with Catabolite repression (S.O.C.) medium. E. coli was grown at 
37 °C (200 rpm) in Lysogeny broth (LB) medium supplemented with appropriate antibiotics. In order to introduce 
the construct into streptomycetes, plasmid DNA was introduced into E. coli ET12567 (pUZ8002) by calcium 
chloride transformation. ET12567 strains were grown in LB supplemented with apramycin (50 μg/mL), chloram-
phenicol (25 μg/mL), and kanamycin (25 μg/mL) for 16 hours, shaking at 200 rpm at 37 °C.
Construction of kirM, kirN, kirHIV, and kirHV gene inactivation plasmids. All primers used in 
this study are listed in Supplementary Table S2. A 2.1 kb cassette, containing the ermE* promoter flanked by 
two 1 kb-fragments up- and downstream of the genes kirM, kirHIV, kirHV, and kirN, were amplified from 
pCRISPR-Cas9_USER- kirM/kirHIV/kirHV/kirN, which were constructed based on a previously described 
method13 (see Supplementary Table S1). For the amplifications, primers KP1 – KP8 and PCR programs listed in 
Supplementary Table S2 were used. Each of the kir cassettes were assembled in pGUSA2114 by Gibson cloning 
carried out at 50 °C for 30 min. Correct clones of pHR1 and pHR3–5 were identified by control PCR and con-
firmed by Sanger sequencing with KP37/KP42.
Construction of kirHVI gene inactivation plasmid. To generate the kirHVI gene inactivation plasmid 
pHR2, 1 kb fragments, flanking the target gene, were amplified from the cosmid 2K05 DNA4 using primers KP9/
KP10 and KP13/KP14. The ermE* promoter was amplified from plasmid pCRISPR-Cas915 with primers KP11/
KP12. 1 M betaine was added to the PCRs to improve amplification of GC-rich stretches. Upon gel purification, 
the three fragments were assembled in pGUSA2114 by Gibson cloning carried out at 50 °C for 30 min, yielding 
pHR2. Correct clones of pHR2 were identified by control PCR and Sanger sequencing with KP37/KP38.
Construction of kirOI and kirOII gene inactivation plasmids. To construct pTL-kirOI, 1.2 kb of the 
flanking regions of the gene were amplified by PCR with primer pairs KP15/KP16 and KP17/KP18 using the 
PCR programs listed in Supplementary Table S2. For construction of pDW-kirOII, 2 kb of the flanking regions 
of kirOII were amplified by PCR with primers KP21/KP22 and KP23/KP24 using the PCR program listed in the 
Supplementary Table S2.
The left and right fragments, up- and downstream of kirOI and kirOII, were cloned into pA18mob resulting in 
the plasmids pTL-kirOI and pDW-kirOII, respectively. The thiostrepton resistance cassette (1.1 kb) was amplified 
from plasmid pSLE6116 with primers KP19/KP20. The 1.1 kb fragment was first cloned into pDrive (Qiagen, 
Hilden, Germany) and then inserted via the XbaI sites into pTL-kirOI and pDW-kirOII, resulting in the plasmids 
pTL-kirOI-thio and pDW-kirOII-thio, respectively. The gene replacement mutants were confirmed by control 
PCRs targeting the apramycin and thiostrepton resistance cassettes with the primer pairs KP39/KP40 and KP19/
KP20, respectively.
To distinguish between wild type and single/double crossover mutants, the primer pairs KP41/KP42 and 
KP43/KP44 were used for amplification of an internal region of (wild type) kirOI/kirOII or the thiostrepton resist-
ance marker (single- or double crossover mutant).
In addition to PCR, Southern Blot analysis was used to confirm correct mutants of kirOI and kirOII. Here, 
the DIG-labelled probe for Southern Blot experiments was amplified from cosmid 1C24 DNA4 with the primer 
pairs KP41/KP42 (kirOI) or KP43/KP44 (kirOII) using a 10 × DIG DNA labelling mix (Roche, Mannheim, 
Germany). Genomic DNA preparation from streptomycetes was performed with the NucleoSpin® Tissue Kit 
from Macherey-Nagel, Düren, Germany.
Intergeneric conjugation in S. collinus Tü 365. To introduce the gene inactivation plasmids into S. col-
linus Tü 365, a standard protocol for intergeneric conjugation was used17. Single crossover mutants were selected 
based on blue-white screening14 in which spore dilution plates were overlaid with 20 mM X-Gluc (5-bromo-
4-chloro-3-indolyl-β-D-glucuronic acid). Control PCR was used to verify the single crossovers using primers 
KP72/KP73. For induction of the double crossover event, two-day-old cultures of single crossover mutants, culti-
vated in TSB medium, were stressed for 24 h at 37 °C, shaking at 160 rpm. Spore dilution plates were overlaid with 
20 mM X-Gluc and white clones were picked for control PCRs with primers KP45 – KP58 (see Supplementary 
Fig. S6).
Construction of complementation plasmids for kirromycin kir mutants. kir genes were PCR 
amplified using the cosmid 2K05 (kirM, kirHVI, kirOI, kirOII, and kirN)4 as template and the primers KP27 – 
KP36. 1 M betaine was added to the PCRs to improve amplification of the GC-rich stretches. The DNA encoding 
the kir genes was purified from gel and cloned into the blunt end pJet1.2 vector as instructed by the manufacturer. 
Correct clones were verified by control PCR and Sanger sequencing with primers KP59/KP60.
pJet1.2 clones of kirM, kirHVI, and kirN were subjected to restriction digestions with NdeI and HindIII 
together with DNA of integrative plasmid pRM418. The pJet1.2 clone of kirOII was subjected to restriction diges-
tion with NheI and HindIII together with pRM4. Finally, pJet1.2-kirOI was subjected to restriction digestion 
with HindIII and EcoRI together with replicative plasmid pGM1190. The genes purified from gel and linearised 
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vectors were ligated using T4 DNA Ligase and introduced into E. coli DH5-α competent cells according to manu-
facturer’s instructions. The complementation plasmids of pGM1190 and pRM4 were verified by control PCR and 
Sanger sequencing with primers KP61/KP62 and KP63/KP64, respectively, and transferred to S. collinus mutant 
strains by standard intergeneric conjugation17.
Kirromycin production assay, HPLC-HRMS, and MS/MS analyses. For the fermentations, 5 mL of 
two days-old precultures (grown in TSB) were used for inoculation of 95 mL kirromycin production medium 
composed of 1% full-fat soy flour, 1% D-mannitol, and 0.5% CaCO3 dissolved in tap water and pH adjusted 
to 7.4 prior to autoclaving. Fermentations were carried out for six days at 30 °C in a rotary shaker at 160 rpm. 
Cultures were extracted with 1:1 ethyl acetate for 90 minutes and evaporated in a Büchi® Rotavapor® RII evap-
orator equipped with jack and water bath. Dried extracts were redissolved in 500 μL methanol. HPLC–HRMS 
analysis was carried out with an Orbitrap Fusion connected to a Dionex Ultimate 3000 UHPLC pumping sys-
tem (ThermoFisher Scientific, Waltham, MA, USA). UV-Vis detection was done using a DAD-3000 set to the 
range 200–600 nm. Samples were kept at 10.0 °C in the autosampler during the analysis. 2 μL of each sample was 
injected into a C18 Acquity UPLC F5–3 HPLC column (2.1 × 100 mm, 1.8 μm,) at a flow rate of 0.4 mL/min, 
30.0 °C. Mobile phases A and B were 0.1% formic acid in water and acetonitrile, respectively. Elution was done 
with a 30 min multistep system. After 5% B for 1 min, a linear gradient started from 5% B to 100% B in 21 min, 
which was held for another 5 min and followed by re-equilibration to 5% B until 30 min. Data was collected in 
both positive and negative ion modes with a scan range of (m/z) = 200–2000. MS/MS fragmentation was carried 
out using Ion Trap for collision-induced dissociation (CID) with the collision energy (30%), RF Lens 60%, AGC 
target 5.0e4, and scan range (m/z) 230–800. Data analyses were performed with the software Xcalibur 3.0.63 
(Thermo Fisher Scientific Inc.).
NMR of 30-deoxy-kirromycin, 5,6-dihydro-kirromycin, and 30-hydroxy-5,6-dehydro-
1-N-demethyl-16-deoxy-kirrothricin. To confirm the structure of the 30-hydroxy-5,6-dehydro-
1-N-demethyl-16-deoxy-kirrothricin (kirromycin-ΔkirOII, 5), a 2L-fermentation of the ΔkirOII mutant was 
carried out using the same production medium and extraction conditions described previously. Pure compound 
5 (2.2 mg) was obtained by separation on a semi-preparative RP-18 column by HPLC. 1D and 2D NMR were 
acquired using standard pulse sequences on an 800 MHz Bruker Avance spectrometer with a 5 mm TCI cryo 
probe at NMR Center, Technical University of Denmark. CD3OD was applied as solvent. Chemical shifts were 
usually expressed in parts per million (ppm, δ) relative to internal standard tetramethylsilane (TMS).
In addition, 30-deoxy-kirromycin (kirromycin-ΔkirHVI, 3), 5,6-dihydro-kirromycin (kirromycin-ΔkirOI, 
4), and 5 were analysed at the Institute of Organic Chemistry at Tübingen University. NMR spectra were recorded 
on Bruker Avance III HDX 700 spectrometer (1 H, 700 MHz; 13 C, 150.8 MHz) with a 5 mm dual (1 H/13 C)-TCI 
cryo probe head at 298 K. Chemical shifts were given in ppm downfield from TMS relative to the solvent as inter-
nal standard (CD3OD, δH 3.30, δC 49.0 ppm).
Results
Sequence analysis of genes and encoded products presumably involved in kirromycin biosyn-
thesis in S. collinus Tü 365. The genes kirM, kirHVI, kirOI, kirOII, kirHIV, kirHV, and kirN are located 
in the kirromycin gene cluster and thus a potential function of their gene products was postulated based on 
sequence analysis using the sequence aligner DIAMOND19 against the MIBiG database (Table 1).
For the tailoring enzymes, the closest homologue of KirM was the O-methyltransferase RapM (75% aa identity 
and 87% similarity), involved in rapamycin biosynthesis in Streptomyces hygroscopicus NRRL 549120. With 31% aa 
identity and 55% similarity, the hydroxylase Fum3p involved in C-5 hydroxylation in fumonisin biosynthesis in 
Gibberella fujikuroi21 was the best hit for KirHVI. When the protein sequence of KirHVI was aligned against the 
Uniprot/Swissprot database, most of the hits were members of the phytanoyl-CoA dioxygenases enzyme family. 
KirOI and KirOII were putatively assigned to cytochrome P450 hydroxylases. KirOI displayed 49% aa identity 
and 64% similarity to the previously characterised cytochrome P450 hydroxylase TiaP2, responsible for hydrox-
ylation of the C-20 residue in tiacumicin B biosynthesis22. For KirOII, the closest characterised homologue (40% 
aa identity and 59% similarity) was found to be the 6-deoxyerythronolide B hydroxylase, encoded by eryF, which 
is involved in biosynthesis of erythromycin in Saccharopolyspora erythraea23.
Gene nt/aa1
MIBiG (1)/UniProt 
KB/Swiss-Prot (2) Highest similarity Putative function S/I2 (%) Closest homologue in
kirM 957/319 1 rapM SAM-dependent O-methyltransferase 87/75 Streptomyces hygroscopicus NRRL 5491
kirHVI 846/282 1 fum3p Hydroxylase 55/31 Gibberella fujikuroi
kirOI 1200/400 1 tiaP2 Cytochrome P450 hydroxylase 64/49 Dactylosporangium aurantiacum subsp. hamdenensis NRRL 18085
kirOII 1218/406 1 eryF Cytochrome P450 hydroxylase 59/40 Saccharopolyspora erythraea NRRL 2338
kirHIV 783/261 2 A0A062 WMT4 Uncharacterised protein 88/76 Frankia sp. BMG5.23
kirHV 396/132 2 A0A1Q5MN63 Uncharacterised protein 80/71 Streptomyces sp. CB00455
kirN 1368/456 1 sfaR Crotonyl-CoA reductase/carboxylase 86/76 Streptomyces flaveolus DSM 9954
Table 1. Results of the sequence analysis of KirM, KirHVI, KirOI, KirOII, KirHIV, KirHV, and KirN 1nt, 
nucleotides; aa, amino acids. 2S, similarity; I, identity.
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Additional proteins downstream of the PKS/NRPS biosynthetic core have remained assigned with hypo-
thetical function as it is the case for KirHIV and KirHV. The sequence analyses of KirHIV and KirHV, using 
DIAMOND19 alignment against the MIBiG database, did not yield any significant hits. Furthermore, based on the 
alignment against the UniProtKB/Swiss-Prot database, KirHIV and KirHV displayed similarity only to proteins 
with uncharacterised functions. Here, the best match for KirHIV (76% aa identity and 88% similarity) was an 
uncharacterised protein found in Frankia sp. BMG5.23. KirHV displayed the highest aa identity and similarity 
(71 and 80%) to an uncharacterised protein from Streptomyces sp. CB00455. Hence, in respect of the sequence 
analyses the functions of KirHIV and KirHV remained elusive.
The gene kirN is located downstream of the PKS I/NRPS-encoding region in the BGC and shows 76% aa 
identity and 86% similarity to the crotonyl-CoA reductase/carboxylase (CCR) SfaR from the sanglifehrin BGC in 
Streptomyces flaveolus DSM 995424 (Table 1). In addition to this, the sequence analysis revealed that kirN displays 
between 70 to 76% aa identity with several other CCRs found in other Streptomyces species.
Gene inactivations of kirM, kirHVI, kirOI, and kirOII result in production of kirromycin deriva-
tives. To determine the role of the six genes presumed to be involved in tailoring reactions, two different gene 
replacement strategies were carried out. For the mutants in kirM, kirHVI, kirHIV, and kirHV, the respective gene 
was replaced by the ermE* promoter, whereas for kirOI and kirOII, a thiostrepton resistance cassette together with 
the ermE* promoter were used to replace the genes. Mutants were verified by control PCRs (see Supplementary 
Fig. S6), which resulted in either the expected bands or no product when the primers targeted internal regions of 
the deleted gene. The confirmed mutant clones were subjected to fermentation experiments carried out in par-
allel batches with wild type S. collinus Tü 365 as reference strain. The cultures were extracted with ethyl acetate, 
concentrated, and the extracts, including kirromycin and its derivatives, were dissolved in methanol. The samples 
were analysed by HPLC-HRMS.
In the 30 min chromatographic method used for separation of kirromycin (1) and its derivatives, 1 appeared 
at 12.2 min with the main ion m/z = 795.4110 [M-H]− (Fig. 2). Furthermore, MS/MS fragmentation of the deriv-
atives was carried out to gain insights into differences in the chemical formulas (see Supplementary Fig. S2). 
Kirromycin derivatives were detected in the mutants of ΔkirM, ΔkirHVI, ΔkirOI, and ΔkirOII (see Fig. 2 
and Supplementary Table S3). Gene inactivations of the hypothetical proteins encoded by kirHIV and kirHV 
did not affect the production of kirromycin and resulted in HPLC-HRMS data similar to the wild type (see 
Supplementary Fig. S1-I and S1-II). Thus, it was concluded that these proteins are not directly involved in kirro-
mycin biosynthesis.
Gene inactivation of kirM resulted in the complete loss of production of 1, and instead the derivative 
20-O-demethyl-kirromycin (kirromycin-ΔkirM, 2), which was only present in low amounts in the wild type 
sample, was the main product of the mutant. With its chemical formula C42H58N2O12, 2 appeared in the chroma-
togram at 11.2 min with m/z = 781.3953 [M-H]− (Fig. 2 and Supplementary Table S3). The MS/MS fragmenta-
tion of 2 gave rise to a fragment ion of m/z = 485.2292 [M-H]− (see Supplementary Fig. S2-II). Compared to the 
fragment ion of 1, which was m/z = 499.2451 [M-H]−, the difference of - Δ14 corresponds to a difference of CH2. 
This is in accordance with the predicted mass of a methyl group and gives strong evidence that KirM catalyses the 
O-methylation at the C-20 position in the kirromycin precursor.
Similar to the ∆kirM mutant, the extracts of ∆kirHVI, ∆kirOI, and ∆kirOII were analysed using HPLC-HRMS 
and HRMS/MS. The chromatograms of these mutants revealed new prominent peaks, which were only 
detected with weak intensities in the extract of the wild type S. collinus Tü 365. Gene inactivation of kirHVI 
Figure 2. HPLC UV-Vis chromatograms and m/z values for kirromycin (1), produced by the wild type 
strain (WT), and derivatives produced by the mutants ΔkirM (2), ΔkirHVI (3), ΔkirOI (4), ΔkirOII (5), and 
ΔkirN::pRM4(kirHVI).
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led to the production of 30-deoxy-kirromycin (kirromycin-ΔkirHVI, 3). Based on the HRMS data (Fig. 2 and 
Supplementary Table S3), the chemical formula of 3 was calculated to be C43H60N2O11 and the corresponding ion 
m/z = 779.4177 [M-H]− appeared at 12.3 min. This derivative was already observed in the chromatogram of the 
WT. In this case, the presence of 3 in the wild type extract could be a pathway intermediate in the biosynthesis 
of kirromycin. MS/MS fragmentation patterns for 1 and 3 yielded the same fragment ion with m/z = 499.2457 
[M-H]− (see Supplementary Fig. S2-I and S2-III). This mass corresponds to a fragmentation at the peptide bond 
at C-2725. As this pyridone-containing fragment is observed in both 1 and 3 this indicated that the hydroxyl 
group is missing on the sugar-containing fragment, presumably at position C-30, of 3 in the ΔkirHVI mutant. 1H 
and 13C NMR and Homonuclear Correlation Spectroscopy (COSY), Heteronuclear Single Quantum Correlation 
(HSQC), and Heteronuclear Multiple Bond Correlation (HMBC) corroborated the putative proposed structure 
of 3 as the analogue 30-deoxy-kirromycin (see Supplementary Table S4, Supplementary Fig. S4-I and Fig. S5-I).
Gene inactivations of the putative P450-dependent hydroxylases encoded by kirOI and kirOII resulted in 
detection of the two derivatives 5,6-dihydro-kirromycin (kirromycin-ΔkirOI, 4) and 30-hydroxy-5,6-dehydro-
1-N-demethyl-16-deoxy-kirrothricin (kirromycin-ΔkirOII, 5) with m/z 797.4286 [M-H]− and 763.4213 [M-H]−, 
which eluted at 13.6 min and 13.5 min, respectively (Fig. 2 and Supplementary Table S3). The chemical formulas 
were predicted to be C43H62N2O12 for compound 4 and C43H60N2O10 for 5. For 4, the MS/MS fragmentation 
data allowed for the assignment of KirOI to the double bond between C-5 and C-6 in the pyridone ring. The 
fragmentation of 4 yielded the fragment ion of m/z = 501.2634 [M-H]−, which is the respective fragment of 
m/z = 499.2451 [M-H]− of 1 (see Supplementary Fig. S2-I and S2-IV). The mass unit difference of + Δ2 could be 
assigned to the gain of two hydrogen atoms for 4 compared to 1. 1D and Two-Dimensional (2D)-NMR analyses 
of 4 confirmed the two CH2 groups at C-5 and C-6 (see Supplementary Table S4, Supplementary Fig. S4-II and 
Fig. S5-II).
In the case of KirOII, the difference of two oxygen atoms underlined the hypothesis of the enzyme being 
involved in oxidation at C-16 and presumably preparing the ring closure to the THF ring. However, the MS/MS 
fragmentation of 5, yielding the main fragment ion of m/z = 467.2548 [M-H]−, did not allow for prediction of 
the exact chemical structure of the derivative (see Supplementary Fig. S2-V). Therefore, NMR analyses, includ-
ing 1H NMR, 13C NMR, COSY, HSQC, and HMBC were undertaken to gain more insight into the structure of 
5 (see Supplementary Table S4, Supplementary Fig. S4-III, and Fig. S5-III). To elucidate the structure of 5, a 2 
L-fermentation of the ΔkirOII mutant strain was carried out. Pure compound 5 (2.2 mg) was obtained by separa-
tion on a semi-preparative RP-18 column by HPLC. The 13C NMR spectrum showed addition signals for double 
bonds and the loss of signals for three oxygen-bearing carbons indicating opening of the furan ring and cor-
roborated the chemical nomenclature 30-hydroxy-5,6-dehydro-1-N-demethyl-16-deoxy-kirrothricin. 2D-NMR 
experiments revealed the tetraene fragment for 5, which is not present in 1 (see Supplementary Table S4 and 
Supplementary Fig. S4-III and S5-III).
To rule out polar effects caused by disruption of the kirromycin BGC, gene complementations for each of 
the mutants, ΔkirM, ΔkirHVI, and ΔkirOII, were carried out using conjugation and the integrative plasmid 
pRM418, and for ΔkirOI using the replicative plasmid pGM1190 (see Supplementary Fig. S3-I–S3-IV). The com-
plemented mutants were fermented in kirromycin production medium, extracted, and the extracts analysed by 
HPLC-HRMS. The complementation of the ΔkirM mutant resulted in similar kirromycin production levels com-
pared to the wild type (100%). For the complementation of the ΔkirHVI mutant, approximately 30% of the wild 
type levels of 1 could be restored, which was confirmed by both MS and UV-Vis quantification. The complemen-
tation of the ΔkirOI and ΔkirOII mutants resulted in only 10% and 20% restored production of 1 compared to 
the wild type levels. Although there was no full complementation for these two mutants, the retention times and 
molecular masses, as determined by HPLC-HRMS, clearly indicated that the observed effects were due to the 
inactivation of the individual genes and not due to polar effects on the biosynthetic assembly line.
Gene inactivation of kirN gives rise to lowered kirromycin production. The ΔkirN mutant was 
constructed based on the previously described GusA system for double crossover14. An ermE* promoter was 
used to replace the gene. The integrative plasmid pRM4 was used to construct the complemented mutant. The 
gene kirN encodes a putative CCR, which is postulated to provide the ethylmalonyl-CoA extender unit for the 
trans-AT KirCII, which then loads this substrate onto KirAII-ACP5. Unexpectedly, a deletion of kirN (ΔkirN) 
resulted in loss of kirromycin production. Instead, derivative 3, which was the main compound observed in the 
ΔkirHVI mutant, was detected. Genetic complementation of the ΔkirN mutant failed to restore production of 1. 
However, upon gene complementation of the ΔkirN mutant with pRM4 harbouring kirHVI, levels of 1 were par-
tially restored (~30% of wild type levels). Since the replacement of kirN with the ermE* promoter was expected to 
drive expression through the downstream gene kirHVI, we examined the genetic organisation. This revealed over-
lapping open reading frames (ORFs) of kirN and kirHVI and it was concluded that the genetic inactivation of kirN 
led to the disruption of downstream gene kirHVI. To test if production of 1 could be fully restored, pRM4 har-
bouring a copy of both kirN and kirHVI was constructed and used for complementation of ΔkirN. This resulted 
in a restoration of 1 in the ΔkirN mutant, reaching between 40–100% of wild type levels (see Supplementary Fig. 
S3-V and S3-VI). Taken together, this data confirmed that the downstream gene kirHVI was affected by the gene 
inactivation of kirN and a full recovery of the production of 1 was only possible when kirN and its neighbouring 
gene kirHVI were encoded on the complementation construct.
Discussion
In this study, the involvement of the seven genes, kirM, kirHVI, kirOI, kirOII, kirHIV, kirHV, and kirN in the 
biosynthesis of kirromycin in S. collinus Tü 365 was investigated experimentally based on gene inactivations, 
complementations, and product analyses by HPLC-HRMS, MS/MS, and NMR.
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Our studies provide experimental evidence that KirM acts as an O-methyltransferase, giving rise to the 
methyl group on O-42 in kirromycin. This finding is further strengthened by comparison of the role of the close 
homologue RapM, which is involved in rapamycin biosynthesis in Streptomyces hygroscopicus NRRL 5491. 
Gene complementation with rapM of the deletion mutant MG2–10 (ΔrapKIJMNOQL) resulted in the restored 
O-methylation at the C-16 position in this molecule20.
Based on the MS/MS fragmentation (see Supplementary Fig. S2-III) and NMR analysis (see Supplementary 
Table S4, Supplementary Fig. S4-I and Fig. S5-I), the main derivative 3, produced by the ΔkirHVI mutant, lacks 
a hydroxyl group at position C-30 in the kirromycin analogue. From the sequence-based alignment against the 
MIBiG database, KirHVI displays similarity to the hydroxylase Fum3p, which is responsible for attachment of 
a hydroxyl group at the C-5 position in fumonisin B produced by Gibberella fujikuroi21. Heterologous expres-
sion of Fum3p in Saccharomyces cerevisiae could clarify the enzymatic function of the protein and based on in 
vitro and in vivo findings it was possible to determine Fum3p to be a 2-ketoglutarate-dependent dioxygenase26. 
Since most protein hits from the UniProtKB/Swiss-Prot sequence alignment of KirHVI belonged to the family 
of phytanoyl-CoA dioxygenases it can be postulated that the hydroxylation catalysed by KirHVI in kirromycin 
biosynthesis occurs in a similar fashion (see Supplementary Fig. S7-I).
Furthermore, the function of KirOI and KirOII has been analysed in this study. According to the data from 
the MS/MS fragmentation and NMR, the ΔkirOI mutant produced the derivative kirromycin-ΔkirOI, which was 
undoubtedly missing the double bond between C-5 and C-6 in the pyridone ring (see Supplementary Table S4, 
Supplementary Fig. S2-IV, Fig. S4-II, and Fig. S5-II). Here, the predicted cytochrome P450 hydroxylase KirOI 
most likely forms a hydroxylated intermediate, which then undergoes dehydrogenation giving rise to the fully 
unsaturated pyridone ring (see Supplementary Fig. S7-II).
The HRMS and MS/MS analyses of the derivative 5, produced by the ΔkirOII mutant, did not provide suffi-
cient data for unambiguous structure prediction. Therefore, 5 was subjected to NMR studies, which enabled us to 
uncover a kirromycin analogue missing the THF ring structure and both hydroxyl groups at positions C-15 and 
C-16 (see Supplementary Table S4, Supplementary Fig. S4-III, and Fig. S4-III) in the kirromycin analogue. Based 
on our current hypothesis, the biosynthesis of kirromycin from 5 might be explained by a mechanism similar to 
that of the cytochrome P450 monooxygenase AurH, which is involved in the conversion of deoxyaureothin to 
aureothin through the formation of two C-O bonds, ultimately giving rise to a THF ring27,28. Similar to AurH, 
KirOII could introduce two hydroxyl groups at C-14 and C-16. Allylic substitution of the hydroxyl system could 
then lead to the formation of the THF ring system at the expense of H2O. The proposed enzymatic pathway is 
presented in Supplementary Fig. S7-III. In the future, enzymatic in vitro assays are necessary to fully establish the 
enzymatic reaction catalysed by KirOII.
Finally, we have studied the putative CCR encoded by kirN, which is expected to be involved in biosynthesis 
of the ethylmalonyl-CoA extender unit incorporated in kirromycin at the C-28 position4. Studies on the involve-
ment of CCRs in both primary and secondary metabolism have led to a revision of their function and today these 
enzymes are known for their involvement in acetyl-CoA assimilation through an alternative pathway distinct 
from the glyoxylate pathway29,30. Furthermore, sequence analysis of actinomycetes has revealed a tendency of 
co-clustering of CCRs with PKSs. This suggests an important role of the CCRs in polyketide derivatization as 
they provide extender units alternative to butyrate, which are incorporated into the polyketide structure30,31. The 
putative role of KirN is further strengthened by the 13C NMR studies on the N-methylated kirromycin analogue 
aurodox, in which Liu et al.32,33 confirmed the incorporation of an intact butyrate unit at the C-28 position in 
the molecule. We suspect that the presence of an additional ccr gene in the genome of S. collinus Tü 365 (locus 
B446_29770 in NCBI GenBank entry CP006259.1), likely involved in the ethylmalonyl pathway to assimilate 
C2-units in primary metabolism29, may give rise to an inherent complementation of ΔkirN. Therefore, complete 
abolishment of kirromycin production was not expected. Surprisingly, the ΔkirN mutant generated in this study 
gave rise to production of 3 instead of the expected lowered production of 1. Examination of the genetic organisa-
tion of the kirromycin BGC revealed the ORF of kirN to overlap with that of kirHVI, hence leading to disruption 
of the latter gene and production of 3. Partial and full restoration of kirromycin production was achieved by 
genetic complementation of ΔkirN with kirHVI separately and with kirN and kirHVI together, respectively (see 
Supplementary Fig. S3-V and S3-VI). The observed phenomenon should be kept in mind for future BGC engi-
neering efforts to account for polar effects in these often tightly regulated systems.
In our study, we demonstrated that the enzymes KirM, KirHVI, KirOI, and KirOII play important roles in late 
stages of the biosynthesis of kirromycin. Derivatives of 1 were detected in all mutants, except for ΔkirN, ΔkirHIV, 
and ΔkirHV. Although the genes kirHIV and kirHV are located in the kirromycin BGC, their inactivation had 
no effect on kirromycin biosynthesis and resulted in similar production profiles in both the wild type and mutant 
clones. Consequently, the data suggest that these hypothetical proteins are not directly involved in kirromycin 
biosynthesis. For the ΔkirN mutant, we observed a reduced production of 1. While the ΔkirM mutant produces 
a derivative missing a methyl group at the O-42 position, the main derivative produced by the ΔkirHVI mutant 
lacks the hydroxyl group at the C-30 position in the sugar-like moiety. Finally, gene inactivations of kirOI and 
kirOII, encoding the two cytochrome P450 hydroxylases, result in a missing double bond in the pyridone ring 
and no THF ring closure, respectively. These results and the new knowledge have allowed us to close some of the 
gaps in the biosynthetic pathway of kirromycin (Fig. 3). Our studies does not allow for determining a defined 
sequence of the tailoring reactions. However, based on our findings, it could be argued that the enzymes act in an 
independent manner.
The better understanding of the complex kirromycin assembly line, which can be regarded as model for hybrid 
cis-/trans-AT PKS I/NRPSs, provides new incentive to the development of novel strategies for the production 
of polyketide derivatives. In particular the ΔkirN mutant, generated and analysed in this study, will support 
the applicability of a previously developed system25. In a previous study, we demonstrated that the promiscuity 
of the trans-AT KirCII, which also accepts non-natural malonate-derived extender units, can be used as a tool 
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for polyketide diversification. By expressing a tailored malonyl-CoA synthetase and feeding of allyl- or prop-
argylmalonic acid externally, the production of allyl- and propargyl-kirromycin was achieved25. However, the 
reported yields of propargyl-kirromycin were low compared to the production of the wild type kirromycin (22% 
propargyl-kirromycin compared to 78% kirromycin), likely due to the higher activity of KirCII towards the native 
substrate ethylmalonyl-CoA34. Hence, the use of the ΔkirN mutant with its impaired ethylmalonyl-CoA biosyn-
thetic pathway is expected to result in improved yields of the novel derivatives.
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